Given better survival in pediatric patients with acute lymphoblastic leukemia (ALL) compared with adolescents and young adults (AYAs), oncologists are exploring the toxicity and overall tolerability of using pediatric-inspired regimens for AYA patients.
Researchers demonstrate the value of genetics evaluation and genetic testing in children, adolescents and young adults with solid tumors. Charis Eng, MD, PhD, gives insight into the largest-to-date evaluation of germline mutations in this population.
A cancer diagnosis is life-changing, but it can be an especially disconcerting time for teenagers and young adults. Cleveland Clinic Cancer Center oncologist Mikkael Sekeres, MD, offers some insights into this special population in his latest New York Times column.
The science of cancer care is advancing at a rapid place, contributing to improvements in the survival of pediatric and older adult patients with cancer. But adolescents and young adults are not seeing the same outcomes, perhaps in part due to their low enrollment rates in cancer clinical trials. Hematologist-oncologist Stefanie Thomas, MD, explains.